Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts. Although the ...
The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Pump.Science’s decentralized model aims to reshape scientific funding and support longevity research, but challenges remain.
After HHS Secretary Robert F. Kennedy Jr. hosted a roundtable on reducing regulations on stem cells earlier this month, ...
City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...
21h
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback